Gene and Cell Therapy – News and Features

Now in its second year, the SCIpharm 2006 conference (May 14-17, EICC, Edinburgh, Scotland) will cover all aspects of modern R&D in a four-track format - Gene to Screen, Screen to Candidate, Candidate to Drug and Where Science Meets Business.

Patent covers any therapeutic gene in combination with radiation and chemotherapy.

Ichor has granted an option for RheoGene to license Ichor’s TriGrid™ Delivery System to develop proprietary therapeutics.

In this Decision Resources report three RNA-based technologies are described.

This versatile package can carry bits of RNA that stop the cell from expressing one of its own genes.

Genzyme bought extensive gene therapy assets from US company Avigen in December.

Researchers used gene therapy to introduce a healthy copy of the gene dystrophin into mice with a condition that mimics muscular dystrophy.

Researchers have created a genetic switch system that is turned on in the presence of the antibiotic tetracycline.

This research demonstrates a way to genetically correct sickle cell disease using RNAi technology.

The program will allow a better understanding of the muscle and the development of therapeutic leads.